1,651
Views
48
CrossRef citations to date
0
Altmetric
Articles

Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder

, MD, , MD, , MD, , MD & , MD, MPH
Pages 494-510 | Received 21 Oct 2015, Accepted 07 Jan 2016, Published online: 23 May 2016

References

  • Ahmadpanah, M., Sabzeiee, P., Hosseini, S. M., Hosseini, S. M., Torabian, S., Haghighi, M., … Brand, S. (2014). Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology, 69(4), 235–242. doi:10.1159/000362243
  • Berger, W., Mendlowicz, M. V., Marques-Portella, C., Kinrys, G., Fontenelle, L. F., Marmar, C. R., & Figueira, I. (2009). Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33(2), 169–180. doi:10.1016/j.pnpbp.2008.12.004
  • Bernardy, N. C., Lund, B. C., Alexander, B., Jenkyn, A. B., Schnurr, P. P., & Friedman, M. J. (2013). Gender differences in prescribing among veterans diagnosed with posttraumatic stress disorder. Journal of General Internal Medicine, 28(Suppl. S2), S542–S548. doi:10.1007/s11606-012-2260-9
  • De Berardis, D., Marini, S., Serroni, N., Iasevoli, F., Tomasetti, C., Bartolomeis, A., … Giannantonio, M. D. (2015). Targeting the noradrenergic system in posttraumatic stress disorder: A systematic review and meta-analysis of prazosin trials. Current Drug Targets, 16(10), 1094–1106. doi:10.2174/1389450116666150506114108
  • Germain, A., Richardson, R., Moul, D. E., Mammen, O., Haas, G., Forman, S. D., … Nofzinger, E. A. (2012). Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US military veterans. Journal of Psychosomatic Research, 72(2), 89–96. doi:10.1016/j.jpsychores.2011.11.010
  • Gradus, J. L. (2015). Epidemiology of PTSD. Retrieved from http://www.ptsd.va.gov/professional/PTSD-overview/epidemiological-facts-ptsd.asp
  • Graham, R. M., Thornell, I. R., Gain, J. M., Bagnoli, C., Oates, H. F., & Stokes, G. S. (1976). Prazosin: The first-dose phenomenon. British Medical Journal, 2(6047), 1293–1294. doi:10.1136/bmj.2.6047.1293
  • Green, B. (2014). Prazosin in the treatment of PTSD. Journal of Psychiatric Practice, 20(4), 253–259. doi:10.1097/01.pra.0000452561.98286.1e
  • Koola, M. M., Sajoy, P., Fawcett, V., & Fawcett, J. A. (2014). High-dose prazosin for the treatment of post-traumatic stress disorder. Therapeutic Advances in Psychopharmacology, 4(1), 43–47. doi:10.1177/2045125313500982
  • Maher, M. J., Rego, S. A., & Asnis, G. M. (2006). Sleep disturbances in patients with post-traumatic stress disorder: Epidemiology, impact and approaches to management. CNS Drugs, 20(7), 567–590. doi:10.2165/00023210-200620070-00003
  • Mellman, T. A., Clark, R. E., & Peacock, W. J. (2003). Prescribing patterns for patients with posttraumatic stress disorder. Psychiatric Services, 54(12), 1618–1621. doi:10.1176/appi.ps.54.12.1618
  • Raskind, M. A., Peskind, E. R., Hoff, D. J., Hart, K. L., Holmes, H. A., Warren, D., … McFall, M. E. (2007). A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biological Psychiatry, 61(8), 928–934. doi:10.1016/j.biopsych.2006.06.032
  • Raskind, M. A., Peskind, E. R., Kanter, E. D., Petrie, E. C., Radant, A., Thompson, C. E., … McFall, M. M. (2003). Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: A placebo-controlled study. American Journal of Psychiatry, 160(2), 371–373. doi:10.1176/appi.ajp.160.2.371
  • Raskind, M. A., Peterson, K., Williams, T., Hoff, D. J., Hart, K., Holmes, H., … Peskind, E. R. (2013). A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. American Journal of Psychiatry, 170(9), 1003–1010. doi:10.1176/appi.ajp.2013.12081133
  • Sareen, J. (2014). Posttraumatic stress disorder in adults: Impact, comorbidity, risk factors, and treatment. Canadian Journal of Psychiatry/Revue Canadienne De Psychiatrie, 59(9), 460–467.
  • Seda, G., Sanchez-Ortuno, M. M., Welsh, C. H., Halbower, A. C., & Edinger, J. D. (2015). Comparative meta-analysis of prazosin and imagery rehearsal therapy for nightmare frequency, sleep quality, and posttraumatic stress. Journal of Clinical Sleep Medicine, 11(1), 11–22.
  • Sjostrom, N., Hetta, J., & Waern, M. (2009). Persistent nightmares are associated with repeat suicide attempt: A prospective study. Psychiatry Research, 170(2–3), 208–211. doi:10.1016/j.psychres.2008.09.006
  • Spoormaker, V. I., Sturm, A., Andrade, K. C., Schroter, M. S., Sturm, A., Goya-Maldonado, R., … Czisch, M. (2010). The neural correlates and temporal sequence of the relationship between shock exposure, disturbed sleep and impaired consolidation of fear extinction. Journal of Psychiatric Research, 44(16), 1121–1128. doi:10.1016/j.jpsychires.2010.04.017
  • Taylor, F. B., Martin, P., Thompson, C., Williams, J., Mellman, T. A., Gross, C., … Raskind, M. A. (2008). Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: A placebo-controlled study. Biological Psychiatry, 63(6), 629–632. doi:10.1016/j.biopsych.2007.07.001
  • Taylor, F. B., & Raskind, M. A. (2002). The alpha-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 22(1), 82–85. doi:10.1097/00004714-200202000-00013
  • Tsujii, T. (2000). Comparison of prazosin, terazosin and tamsulosin in the treatment of symptomatic benign prostatic hyperplasia: A short-term open, randomized multicenter study. International Journal of Urology, 7(6), 199–205. doi:10.1046/j.1442-2042.2000.00175.x
  • Writer, B. W., Meyer, E. G., & Schillerstrom, J. E. (2014). Prazosin for military combat-related PTSD nightmares: A critical review. Journal of Neuropsychiatry and Clinical Neurosciences, 26(1), 24–33. doi:10.1176/appi.neuropsych.13010006

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.